Potential role of EPB41L3 (Protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.12.7.845
Reference70 articles.
1. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation
2. Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis
3. The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor
4. FRMD3, a novel putative tumour suppressor in NSCLC
5. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: Clinical significance and applications;HISTOL HISTOPATHOL;2024
2. EPB41L3 Inhibits the Progression of Cervical Cancer Via the ERK/p38 MAPK Signaling Pathway;Molecular Biotechnology;2024-06-21
3. Machine learning and integrative analysis identify the common pathogenesis of azoospermia complicated with COVID-19;Frontiers in Immunology;2023-05-22
4. The Role of Cytoskeleton Protein 4.1 in Immunotherapy;International Journal of Molecular Sciences;2023-02-14
5. Over-expression of EPB41L3 promotes apoptosis of human cervical carcinoma cells through PI3K/AKT signaling;Acta Biochimica Polonica;2022-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3